Welcome

Sign out Have a question? We're here to help

Sign out

Atara Biotherap (ATRA)

$7.53 0.65 (7.95%)

17:10 EDT ATRA Stock Quote Delayed 20 Minutes

Volume:

Previous Close $7.53

Market Cap 330.94M

PE Ratio -1.81

EPS -4.17

Volume (Avg. Vol.) 706,100

Day's Range 7.35 - 8.28

52-Week Range 4.52 - 41.93

Dividend & Yield N/A (N/A)

ATRA Stock Predictions, Articles, and Atara Biotherap News

From InvestorPlace
From the Web

7 Disruptive Biotech Stocks to Buy for 2025

By Harriet Lefton, Writer, TipRanks Jan 6, 2020

RBC Capital has peered into its crystal ball to reveal some of the market's most exciting biotech stocks. Here are seven that stand out.

5 Biotech Stocks to Sell Amid the Latest Slaughter

By Anthony Mirhaydari, InvestorPlace Market Strategist Feb 28, 2018

These five biotech stocks are being hit particularly hard right now. Here's what investors should know about each of these stocks to sell.

Best & Worst Performing Small Cap Stocks for March 18, 2020

From StockNews.com Mar 18, 2020

ETTX – ETTX leads the way today as the best performing small cap stock, closing up 175.25%.

The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates

From Benzinga Mar 18, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) BioNTech SE – ADR...

The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO

From Benzinga Mar 12, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment

From Benzinga Mar 11, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics...

Atara Biotherapeutics (ATRA) Received its Third Buy in a Row

From Smarter Analyst Mar 3, 2020

After Mizuho Securities and William Blair gave Atara Biotherapeutics (NASDAQ: ATRA) a Buy rating last month, the company received another Buy, this time

The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO

From Benzinga Feb 28, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (...

Navellier Ratings

Total Grade

Strong Sell

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Atara Biotherap (ATRA)

Navellier Ratings

Total Grade

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Atara Biotherap (ATRA)

ATRA Stock Predictions, Articles, and Atara Biotherap News

Navellier Ratings

Total Grade

Subscriber Sign in